Medical
Technology
Pharmaceutical

Antares Pharma

$3.14
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (1.13%) As of 10:10 AM EDT today
+$0.03 (1.13%) Today

Why Robinhood?

You can buy or sell Antares Pharma and other stocks, options, ETFs, and crypto commission-free!

About ATRS

Antares Pharma, Inc. engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Its proprietary products include XYOSTED (testosterone enanthate) injection, OTREXUP (methotrexate) injection for subcutaneous use, and Sumatriptan Injection. Read More The company was founded in February 1979 and is headquartered in Ewing, NJ.

Employees
165
Headquarters
Ewing, New Jersey
Founded
1979
Market Cap
503.84M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.12M
High Today
$3.15
Low Today
$3.11
Open Price
$3.13
Volume
73.02K
52 Week High
$3.96
52 Week Low
$2.53

Collections

Medical
Technology
Pharmaceutical
Health
US
North America

ATRS Earnings

-$0.04
-$0.01
$0.01
$0.04
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 6, Pre-Market

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.